Header Logo

Connection

SANDRA GRIMM to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications SANDRA GRIMM has written about Breast Neoplasms.
SANDRA GRIMM
Connection Strength
0.557
Breast Neoplasms
  1. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer. Cancer Res. 2024 01 16; 84(2):291-304.
    View in: PubMed
    Score: 0.096
  2. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):191-204.
    View in: PubMed
    Score: 0.091
  3. Hormonal modulation of ESR1 mutant metastasis. Oncogene. 2021 02; 40(5):997-1011.
    View in: PubMed
    Score: 0.077
  4. RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer. 2021 01; 124(1):191-206.
    View in: PubMed
    Score: 0.077
  5. Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling. J Cell Biochem. 2020 07; 121(7):3465-3478.
    View in: PubMed
    Score: 0.072
  6. The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast. J Mammary Gland Biol Neoplasia. 2018 12; 23(4):237-248.
    View in: PubMed
    Score: 0.067
  7. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer. Cancer Res. 2017 07 15; 77(14):3802-3813.
    View in: PubMed
    Score: 0.060
  8. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene. 1998 Oct 22; 17(16):2107-13.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.